Stroke Trial, Recruiting (NCT07691411)

Stroke Trial, Recruiting NCT07691411 Sponsor: The Hong Kong Polytechnic University Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT07691411 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have been formally diagnosed with a stroke
People who speak Cantonese well enough to understand and respond to questions and prompts during the study
People who score 18 or higher on a memory and thinking test called the Hong Kong Montreal Cognitive Assessment (HK-MoCA), indicating mild or no cognitive difficulties
People who own and use a smartphone

Who may not be able to join:

People who score 17 or lower on the HK-MoCA test, which indicates moderate to severe difficulties with memory and thinking
People who have an active mental health condition other than depression, such as schizophrenia or bipolar disorder
People who have a terminal illness or a health condition where life expectancy is expected to be limited
People who are bedbound or have a condition that significantly affects their ability to care for themselves

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Arkers KC Wong, PhD, The Hong Kong Polytechnic University

Phone: +852 34003805

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07691411

Sponsor: The Hong Kong Polytechnic University

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +852 34003805

More information: https://clinicaltrials.gov/study/NCT07691411

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have been formally diagnosed with a stroke
People who speak Cantonese well enough to understand and respond to questions and prompts during the study
People who score 18 or higher on a memory and thinking test called the Hong Kong Montreal Cognitive Assessment (HK-MoCA), indicating mild or no cognitive difficulties
People who own and use a smartphone

Who may not be able to join:

People who score 17 or lower on the HK-MoCA test, which indicates moderate to severe difficulties with memory and thinking
People who have an active mental health condition other than depression, such as schizophrenia or bipolar disorder
People who have a terminal illness or a health condition where life expectancy is expected to be limited
People who are bedbound or have a condition that significantly affects their ability to care for themselves

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Hong Kong Polytechnic University

Registry

ClinicalTrials.gov

Start date

6 January 2026

Est. completion

30 September 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Feasibility of the study: acceptance; Feasibility of the study: adherence; Feasibility of the study: experience of the participants in using the app

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov